Your browser doesn't support javascript.
Pause in immunosuppressive treatment results in improved immune response to SARS-CoV-2 vaccine in autoimmune patient: a case report.
Golding, Basil; Lee, Youri; Golding, Hana; Khurana, Surender.
  • Golding B; Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, USA.
  • Lee Y; Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, USA.
  • Golding H; Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, USA.
  • Khurana S; Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, USA Surender.Khurana@fda.hhs.gov.
Ann Rheum Dis ; 80(10): 1359-1361, 2021 10.
Article in English | MEDLINE | ID: covidwho-1316932

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunocompromised Host / COVID-19 Vaccines / COVID-19 / Immunosuppressive Agents / Myasthenia Gravis Type of study: Case report / Observational study Topics: Vaccines Limits: Aged / Humans / Male Language: English Journal: Ann Rheum Dis Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2021-220993

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunocompromised Host / COVID-19 Vaccines / COVID-19 / Immunosuppressive Agents / Myasthenia Gravis Type of study: Case report / Observational study Topics: Vaccines Limits: Aged / Humans / Male Language: English Journal: Ann Rheum Dis Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2021-220993